Patent covers use of AI-ECG for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart disease April 24, 2024 09:00 ET| Source: Heart Test Laboratories, Inc.Follow Southlake, Texas, April 24, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence […]
For HeartSciences CEO Andrew Simpson, the pandemic’s fallout only underscores the urgent need for better cardiac diagnostic tools. HeartSciences Bets Big on AI Amid Surging Heart Disease Deaths In a bold move that could reshape the fight against America’s top killer, medical technology startup HeartSciences is going all-in on artificial intelligence. The company recently announced that it’s shifting its […]
© Provided by New York Tech In recent news, HeartSciences has made significant strides in the fight against heart disease among diabetic patients. Their groundbreaking AI-ECG device, MyoVista, has shown remarkable promise in detecting cardiac issues in those with Type 2 diabetes. This comes at a crucial time, as the company gears up for FDA approval […]
March 26, 2024 Data Demonstrated the Use of MyoVista wavECGTM for Screening Preoperative Patients for LVDD Can Be Recommended Southlake, Texas, March 26, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection […]
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes March 12, 2024 Data Demonstrated MyoVista AI-ECG model significantly outperformed NT-proBNP and ARIC HF score, the conventional standards of care for Stage B Heart Failure screening Southlake, Texas, March 12, 2024 (GLOBE NEWSWIRE) — Heart […]
March 6, 2024 Southlake, TX, March 06, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that the Canadian Intellectual Property Office Application No. 3,000,369 has been […]
Excerpt from the Today Show. Watch the video using the following link: heartsciences.com/wp-content/uploads/2024/02/The-cutting-edge-way-doctors-are-using-AI-to-save-lives_1.mp4
How AI is Reshaping Diagnostic Tools In healthcare, innovation saves lives. From the ECG discovery in 1895 to today’s AI breakthroughs, now AI is changing medicine. March 1, 2024 https://www.techiexpert.com/how-ai-is-reshaping-diagnostic-tools/ SHARE In healthcare, new ideas have always helped save lives. From the discovery of the electrocardiogram (ECG) by Willem Einthoven in 1895 to the […]
February 1, 2024 Southlake, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the appointment of Benjamin Glicksberg, Ph.D. to its Scientific Advisory Board. […]
Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyse and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests for cardiac disease. Supercharging the ECG: AI set to Revolutionise the Diagnostic Cardiology Market – Signify Research
©2023. ™ Trademark of HeartSciences. Reg. US Pat. & TM off. All Rights Reserved.
MV-WBSTE-001 Rev B
wavECG and wavEKG are trademarks of HeartSciences.
